HTG Molecular Diagnostics, Inc. Stock
Stocks
HTGMQ
US40434H3021
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
17:08:37 01/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.00% |
|
0.00% | -99.00% |
| 21/05/25 | Motion For Case Conversion Approved for HTG Molecular Diagnostics, Inc. | CI |
| 28/04/25 | Motion for Case Conversion Filed by HTG Molecular Diagnostics, Inc. | CI |
| Market Cap | 2.88K 2.48K 2.35K 2.13K 3.99K 275K 4.01K 27.89K 10.72K 140K 10.81K 10.57K 442K | P/E 2021 |
-2.19x | P/E 2022 | -0.16x |
|---|---|---|---|---|---|
| Enterprise Value | -3.41M -2.94M -2.78M -2.52M -4.73M -326M -4.75M -33.03M -12.7M -166M -12.8M -12.52M -524M | EV / Sales 2021 |
3.96x | EV / Sales 2022 | 0.04x |
| Free-Float |
99.86% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -99.00% |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0.37 | |
| 5 years | 0 | 75.96 | |
| 10 years | 0 | 2,385 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/8/23 A | Sell | Senior VP of Therapeutics | 888 | 0.0401% | ||
| 3/31/23 A | Tax | Senior VP of Therapeutics | 52 | 0.0056% | - | |
| 2/2/23 A | Other | Senior VP of Therapeutics | 7,610 | 0.8264% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -99.00% | 0.00% | - | - | 2 | ||
| +0.87% | -1.81% | +20.83% | -28.73% | 16.73B | ||
| -1.77% | +5.22% | -35.05% | +55.90% | 1.75B | ||
| +0.08% | -4.28% | -28.36% | +24.66% | 893M | ||
| -3.05% | -15.68% | -58.77% | -84.02% | 808M | ||
| -0.05% | -0.27% | +63.36% | -1.86% | 778M | ||
| -2.56% | -5.17% | -38.85% | -50.56% | 637M | ||
| -5.26% | -9.59% | -43.32% | -52.47% | 560M | ||
| +3.41% | -14.92% | -44.30% | -37.49% | 450M | ||
| +2.02% | +0.62% | -7.77% | -7.88% | 397M | ||
| Average | -10.53% | -4.31% | -19.14% | -20.27% | 2.3B | |
| Weighted average by Cap. | +0.30% | -2.06% | +8.33% | -22.24% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 8.91M 7.67M 7.27M 6.59M 12.36M 851M 12.42M 86.3M 33.19M 433M 33.45M 32.72M 1.37B | 6.37M 5.49M 5.19M 4.71M 8.83M 608M 8.88M 61.68M 23.72M 309M 23.91M 23.38M 978M |
| Net income | -17.15M -14.77M -13.99M -12.68M -23.78M -1.64B -23.91M -166M -63.88M -833M -64.39M -62.98M -2.63B | -21.59M -18.61M -17.62M -15.97M -29.96M -2.06B -30.11M -209M -80.46M -1.05B -81.1M -79.32M -3.32B |
| Net Debt | -5.74M -4.94M -4.68M -4.24M -7.96M -548M -8M -55.58M -21.37M -279M -21.54M -21.07M -881M | -3.41M -2.94M -2.78M -2.52M -4.73M -326M -4.76M -33.06M -12.71M -166M -12.81M -12.53M -524M |
Employees
54
- Stock Market
- Stocks
- HTGMQ Stock
Select your edition
All financial news and data tailored to specific country editions
















